1789 — AK Medical Holdings Income Statement
0.000.00%
Last trade - 00:00- HK$7.05bn
- HK$5.58bn
- CNY1.48bn
Annual income statement for AK Medical Holdings, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IFRS | IFRS | IFRS | IFRS | — |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 761 | 1,052 | 1,094 | 1,346 | 1,482 |
| Cost of Revenue | |||||
| Gross Profit | 499 | 636 | 674 | 808 | 897 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 662 | 832 | 882 | 1,046 | 1,109 |
| Operating Profit | 99.4 | 220 | 211 | 301 | 374 |
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | 109 | 240 | 231 | 320 | 395 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 92.6 | 205 | 182 | 274 | 339 |
| Net Income Before Extraordinary Items | |||||
| Net Income | 92.6 | 205 | 182 | 274 | 339 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 92.6 | 205 | 182 | 274 | 339 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.083 | 0.197 | 0.163 | 0.245 | 0.303 |
| Dividends per Share |